nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Antazoline—Diphenhydramine—atopic dermatitis	0.692	1	CrCrCtD
Phentolamine—Nasal congestion—Diphenhydramine—atopic dermatitis	0.00367	0.0133	CcSEcCtD
Phentolamine—Nasal congestion—Pimecrolimus—atopic dermatitis	0.00355	0.0128	CcSEcCtD
Phentolamine—Hypotensive—Dexamethasone—atopic dermatitis	0.00354	0.0128	CcSEcCtD
Phentolamine—Hypotensive—Betamethasone—atopic dermatitis	0.00354	0.0128	CcSEcCtD
Phentolamine—Abdominal pain upper—Pimecrolimus—atopic dermatitis	0.00296	0.0107	CcSEcCtD
Phentolamine—Mediastinal disorder—Desonide—atopic dermatitis	0.00286	0.0103	CcSEcCtD
Phentolamine—Nasal congestion—Mometasone—atopic dermatitis	0.00243	0.00878	CcSEcCtD
Phentolamine—SIGMAR1—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.00241	1	CbGdCrCtD
Phentolamine—Abdominal pain upper—Loratadine—atopic dermatitis	0.00235	0.00851	CcSEcCtD
Phentolamine—Peptic ulcer—Prednisolone—atopic dermatitis	0.00232	0.00838	CcSEcCtD
Phentolamine—Peptic ulcer—Hydrocortisone—atopic dermatitis	0.00226	0.00818	CcSEcCtD
Phentolamine—Nervous system disorder—Desonide—atopic dermatitis	0.00221	0.00798	CcSEcCtD
Phentolamine—Peptic ulcer—Triamcinolone—atopic dermatitis	0.00213	0.0077	CcSEcCtD
Phentolamine—Peptic ulcer—Methylprednisolone—atopic dermatitis	0.00213	0.00769	CcSEcCtD
Phentolamine—Flushing—Pimecrolimus—atopic dermatitis	0.00208	0.00751	CcSEcCtD
Phentolamine—Mediastinal disorder—Pimecrolimus—atopic dermatitis	0.00202	0.00729	CcSEcCtD
Phentolamine—Peptic ulcer—Betamethasone—atopic dermatitis	0.00193	0.00699	CcSEcCtD
Phentolamine—Peptic ulcer—Dexamethasone—atopic dermatitis	0.00193	0.00699	CcSEcCtD
Phentolamine—Nasal congestion—Tacrolimus—atopic dermatitis	0.00193	0.00698	CcSEcCtD
Phentolamine—Pain—Desonide—atopic dermatitis	0.00193	0.00696	CcSEcCtD
Phentolamine—Nervous system disorder—Fluocinonide—atopic dermatitis	0.00179	0.00647	CcSEcCtD
Phentolamine—Peptic ulcer—Prednisone—atopic dermatitis	0.00168	0.00609	CcSEcCtD
Phentolamine—Orthostatic hypotension—Tacrolimus—atopic dermatitis	0.00161	0.00581	CcSEcCtD
Phentolamine—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00161	0.0058	CcSEcCtD
Phentolamine—Tachycardia—Diphenhydramine—atopic dermatitis	0.00161	0.0058	CcSEcCtD
Phentolamine—Pruritus—Desonide—atopic dermatitis	0.00159	0.00576	CcSEcCtD
Phentolamine—Arrhythmia—Loratadine—atopic dermatitis	0.00159	0.00576	CcSEcCtD
Phentolamine—Pain—Fluocinonide—atopic dermatitis	0.00156	0.00564	CcSEcCtD
Phentolamine—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00156	0.00564	CcSEcCtD
Phentolamine—Hypotension—Diphenhydramine—atopic dermatitis	0.00154	0.00556	CcSEcCtD
Phentolamine—Hypotension—Dimenhydrinate—atopic dermatitis	0.00154	0.00556	CcSEcCtD
Phentolamine—Angina pectoris—Tacrolimus—atopic dermatitis	0.00148	0.00536	CcSEcCtD
Phentolamine—Paraesthesia—Dimenhydrinate—atopic dermatitis	0.00148	0.00534	CcSEcCtD
Phentolamine—Paraesthesia—Diphenhydramine—atopic dermatitis	0.00148	0.00534	CcSEcCtD
Phentolamine—Mediastinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00144	0.00522	CcSEcCtD
Phentolamine—Paraesthesia—Pimecrolimus—atopic dermatitis	0.00143	0.00516	CcSEcCtD
Phentolamine—Headache—Desonide—atopic dermatitis	0.00141	0.0051	CcSEcCtD
Phentolamine—Mediastinal disorder—Mometasone—atopic dermatitis	0.00138	0.00498	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.00137	0.00496	CcSEcCtD
Phentolamine—Pain—Pimecrolimus—atopic dermatitis	0.00136	0.00492	CcSEcCtD
Phentolamine—Hypertension—Loratadine—atopic dermatitis	0.00134	0.00484	CcSEcCtD
Phentolamine—Acute coronary syndrome—Tacrolimus—atopic dermatitis	0.00134	0.00483	CcSEcCtD
Phentolamine—Myocardial infarction—Tacrolimus—atopic dermatitis	0.00133	0.00481	CcSEcCtD
Phentolamine—Chest pain—Loratadine—atopic dermatitis	0.00132	0.00478	CcSEcCtD
Phentolamine—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.0013	0.0047	CcSEcCtD
Phentolamine—Pruritus—Fluocinonide—atopic dermatitis	0.00129	0.00467	CcSEcCtD
Phentolamine—Abdominal pain—Pimecrolimus—atopic dermatitis	0.00126	0.00454	CcSEcCtD
Phentolamine—Nervous system disorder—Loratadine—atopic dermatitis	0.00124	0.00449	CcSEcCtD
Phentolamine—Bradycardia—Tacrolimus—atopic dermatitis	0.00124	0.00448	CcSEcCtD
Phentolamine—Tachycardia—Loratadine—atopic dermatitis	0.00124	0.00447	CcSEcCtD
Phentolamine—Dizziness—Fluocinonide—atopic dermatitis	0.00121	0.00436	CcSEcCtD
Phentolamine—Hypotension—Loratadine—atopic dermatitis	0.00118	0.00428	CcSEcCtD
Phentolamine—Asthenia—Dimenhydrinate—atopic dermatitis	0.00118	0.00427	CcSEcCtD
Phentolamine—Asthenia—Diphenhydramine—atopic dermatitis	0.00118	0.00427	CcSEcCtD
Phentolamine—Headache—Fluocinonide—atopic dermatitis	0.00114	0.00413	CcSEcCtD
Phentolamine—Paraesthesia—Loratadine—atopic dermatitis	0.00114	0.00411	CcSEcCtD
Phentolamine—Chest pain—Mometasone—atopic dermatitis	0.00113	0.0041	CcSEcCtD
Phentolamine—Cardiac disorder—Tacrolimus—atopic dermatitis	0.00113	0.00409	CcSEcCtD
Phentolamine—Flushing—Tacrolimus—atopic dermatitis	0.00113	0.00409	CcSEcCtD
Phentolamine—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00113	0.00407	CcSEcCtD
Phentolamine—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00113	0.00407	CcSEcCtD
Phentolamine—Pruritus—Pimecrolimus—atopic dermatitis	0.00113	0.00407	CcSEcCtD
Phentolamine—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00112	0.00404	CcSEcCtD
Phentolamine—Angiopathy—Tacrolimus—atopic dermatitis	0.00111	0.00399	CcSEcCtD
Phentolamine—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.0011	0.00397	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00109	0.00395	CcSEcCtD
Phentolamine—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00109	0.00393	CcSEcCtD
Phentolamine—Arrhythmia—Tacrolimus—atopic dermatitis	0.00109	0.00393	CcSEcCtD
Phentolamine—Dizziness—Dimenhydrinate—atopic dermatitis	0.00109	0.00393	CcSEcCtD
Phentolamine—Dizziness—Diphenhydramine—atopic dermatitis	0.00109	0.00393	CcSEcCtD
Phentolamine—Pain—Loratadine—atopic dermatitis	0.00108	0.00392	CcSEcCtD
Phentolamine—Vomiting—Dimenhydrinate—atopic dermatitis	0.00105	0.00378	CcSEcCtD
Phentolamine—Vomiting—Diphenhydramine—atopic dermatitis	0.00105	0.00378	CcSEcCtD
Phentolamine—Gastrointestinal pain—Loratadine—atopic dermatitis	0.00104	0.00374	CcSEcCtD
Phentolamine—Headache—Dimenhydrinate—atopic dermatitis	0.00103	0.00372	CcSEcCtD
Phentolamine—Headache—Diphenhydramine—atopic dermatitis	0.00103	0.00372	CcSEcCtD
Phentolamine—Vomiting—Pimecrolimus—atopic dermatitis	0.00101	0.00365	CcSEcCtD
Phentolamine—Abdominal pain upper—Hydrocortisone—atopic dermatitis	0.001	0.00363	CcSEcCtD
Phentolamine—Abdominal pain—Loratadine—atopic dermatitis	0.001	0.00362	CcSEcCtD
Phentolamine—Headache—Pimecrolimus—atopic dermatitis	0.000997	0.0036	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000983	0.00355	CcSEcCtD
Phentolamine—Nausea—Diphenhydramine—atopic dermatitis	0.000977	0.00353	CcSEcCtD
Phentolamine—Nausea—Dimenhydrinate—atopic dermatitis	0.000977	0.00353	CcSEcCtD
Phentolamine—Paraesthesia—Mometasone—atopic dermatitis	0.000976	0.00353	CcSEcCtD
Phentolamine—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000974	0.00352	CcSEcCtD
Phentolamine—Nausea—Pimecrolimus—atopic dermatitis	0.000945	0.00341	CcSEcCtD
Phentolamine—Pain—Mometasone—atopic dermatitis	0.00093	0.00336	CcSEcCtD
Phentolamine—Hypertension—Tacrolimus—atopic dermatitis	0.000916	0.00331	CcSEcCtD
Phentolamine—Asthenia—Loratadine—atopic dermatitis	0.000909	0.00329	CcSEcCtD
Phentolamine—Chest pain—Tacrolimus—atopic dermatitis	0.000903	0.00326	CcSEcCtD
Phentolamine—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000889	0.00321	CcSEcCtD
Phentolamine—Diarrhoea—Loratadine—atopic dermatitis	0.000867	0.00313	CcSEcCtD
Phentolamine—Abdominal pain—Mometasone—atopic dermatitis	0.00086	0.00311	CcSEcCtD
Phentolamine—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.000854	0.00309	CcSEcCtD
Phentolamine—Myocardial infarction—Prednisolone—atopic dermatitis	0.00085	0.00307	CcSEcCtD
Phentolamine—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000849	0.00307	CcSEcCtD
Phentolamine—Tachycardia—Tacrolimus—atopic dermatitis	0.000845	0.00305	CcSEcCtD
Phentolamine—Dizziness—Loratadine—atopic dermatitis	0.000838	0.00303	CcSEcCtD
Phentolamine—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.000834	0.00302	CcSEcCtD
Phentolamine—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.00083	0.003	CcSEcCtD
Phentolamine—Hypotension—Tacrolimus—atopic dermatitis	0.000809	0.00292	CcSEcCtD
Phentolamine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000806	0.00291	CcSEcCtD
Phentolamine—Vomiting—Loratadine—atopic dermatitis	0.000806	0.00291	CcSEcCtD
Phentolamine—Headache—Loratadine—atopic dermatitis	0.000794	0.00287	CcSEcCtD
Phentolamine—Bradycardia—Prednisolone—atopic dermatitis	0.000792	0.00286	CcSEcCtD
Phentolamine—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.000786	0.00284	CcSEcCtD
Phentolamine—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000784	0.00283	CcSEcCtD
Phentolamine—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000781	0.00282	CcSEcCtD
Phentolamine—Asthenia—Mometasone—atopic dermatitis	0.00078	0.00282	CcSEcCtD
Phentolamine—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.00078	0.00282	CcSEcCtD
Phentolamine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000779	0.00282	CcSEcCtD
Phentolamine—Paraesthesia—Tacrolimus—atopic dermatitis	0.000777	0.00281	CcSEcCtD
Phentolamine—Bradycardia—Hydrocortisone—atopic dermatitis	0.000774	0.0028	CcSEcCtD
Phentolamine—Pruritus—Mometasone—atopic dermatitis	0.000769	0.00278	CcSEcCtD
Phentolamine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000753	0.00272	CcSEcCtD
Phentolamine—Nausea—Loratadine—atopic dermatitis	0.000753	0.00272	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000747	0.0027	CcSEcCtD
Phentolamine—Diarrhoea—Mometasone—atopic dermatitis	0.000744	0.00269	CcSEcCtD
Phentolamine—Pain—Tacrolimus—atopic dermatitis	0.00074	0.00267	CcSEcCtD
Phentolamine—Bradycardia—Triamcinolone—atopic dermatitis	0.000728	0.00263	CcSEcCtD
Phentolamine—Bradycardia—Methylprednisolone—atopic dermatitis	0.000727	0.00263	CcSEcCtD
Phentolamine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000724	0.00262	CcSEcCtD
Phentolamine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000713	0.00258	CcSEcCtD
Phentolamine—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000713	0.00258	CcSEcCtD
Phentolamine—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000713	0.00258	CcSEcCtD
Phentolamine—Myocardial infarction—Betamethasone—atopic dermatitis	0.000709	0.00256	CcSEcCtD
Phentolamine—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000709	0.00256	CcSEcCtD
Phentolamine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000708	0.00256	CcSEcCtD
Phentolamine—Arrhythmia—Prednisolone—atopic dermatitis	0.000695	0.00251	CcSEcCtD
Phentolamine—Vomiting—Mometasone—atopic dermatitis	0.000691	0.0025	CcSEcCtD
Phentolamine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000684	0.00247	CcSEcCtD
Phentolamine—Headache—Mometasone—atopic dermatitis	0.000681	0.00246	CcSEcCtD
Phentolamine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000679	0.00245	CcSEcCtD
Phentolamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000676	0.00244	CcSEcCtD
Phentolamine—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000663	0.00239	CcSEcCtD
Phentolamine—Bradycardia—Dexamethasone—atopic dermatitis	0.000661	0.00239	CcSEcCtD
Phentolamine—Bradycardia—Betamethasone—atopic dermatitis	0.000661	0.00239	CcSEcCtD
Phentolamine—Angiopathy—Methylprednisolone—atopic dermatitis	0.000648	0.00234	CcSEcCtD
Phentolamine—Nausea—Mometasone—atopic dermatitis	0.000646	0.00233	CcSEcCtD
Phentolamine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000643	0.00233	CcSEcCtD
Phentolamine—Arrhythmia—Triamcinolone—atopic dermatitis	0.000639	0.00231	CcSEcCtD
Phentolamine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000638	0.0023	CcSEcCtD
Phentolamine—Asthenia—Tacrolimus—atopic dermatitis	0.000621	0.00224	CcSEcCtD
Phentolamine—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000621	0.00224	CcSEcCtD
Phentolamine—Myocardial infarction—Prednisone—atopic dermatitis	0.000617	0.00223	CcSEcCtD
Phentolamine—Pruritus—Tacrolimus—atopic dermatitis	0.000612	0.00221	CcSEcCtD
Phentolamine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000592	0.00214	CcSEcCtD
Phentolamine—Angiopathy—Dexamethasone—atopic dermatitis	0.000589	0.00213	CcSEcCtD
Phentolamine—Angiopathy—Betamethasone—atopic dermatitis	0.000589	0.00213	CcSEcCtD
Phentolamine—Hypertension—Prednisolone—atopic dermatitis	0.000585	0.00211	CcSEcCtD
Phentolamine—Arrhythmia—Betamethasone—atopic dermatitis	0.00058	0.0021	CcSEcCtD
Phentolamine—Arrhythmia—Dexamethasone—atopic dermatitis	0.00058	0.0021	CcSEcCtD
Phentolamine—Bradycardia—Prednisone—atopic dermatitis	0.000576	0.00208	CcSEcCtD
Phentolamine—Dizziness—Tacrolimus—atopic dermatitis	0.000572	0.00207	CcSEcCtD
Phentolamine—Hypertension—Hydrocortisone—atopic dermatitis	0.000571	0.00206	CcSEcCtD
Phentolamine—Vomiting—Tacrolimus—atopic dermatitis	0.00055	0.00199	CcSEcCtD
Phentolamine—Headache—Tacrolimus—atopic dermatitis	0.000542	0.00196	CcSEcCtD
Phentolamine—Tachycardia—Prednisolone—atopic dermatitis	0.00054	0.00195	CcSEcCtD
Phentolamine—Hypertension—Triamcinolone—atopic dermatitis	0.000538	0.00194	CcSEcCtD
Phentolamine—Hypertension—Methylprednisolone—atopic dermatitis	0.000537	0.00194	CcSEcCtD
Phentolamine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000529	0.00191	CcSEcCtD
Phentolamine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000527	0.0019	CcSEcCtD
Phentolamine—Flushing—Prednisone—atopic dermatitis	0.000525	0.0019	CcSEcCtD
Phentolamine—Nausea—Tacrolimus—atopic dermatitis	0.000514	0.00186	CcSEcCtD
Phentolamine—Angiopathy—Prednisone—atopic dermatitis	0.000513	0.00185	CcSEcCtD
Phentolamine—Arrhythmia—Prednisone—atopic dermatitis	0.000505	0.00183	CcSEcCtD
Phentolamine—Hypotension—Hydrocortisone—atopic dermatitis	0.000504	0.00182	CcSEcCtD
Phentolamine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000497	0.0018	CcSEcCtD
Phentolamine—Paraesthesia—Prednisolone—atopic dermatitis	0.000496	0.00179	CcSEcCtD
Phentolamine—Tachycardia—Triamcinolone—atopic dermatitis	0.000496	0.00179	CcSEcCtD
Phentolamine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000495	0.00179	CcSEcCtD
Phentolamine—Hypertension—Betamethasone—atopic dermatitis	0.000488	0.00176	CcSEcCtD
Phentolamine—Hypertension—Dexamethasone—atopic dermatitis	0.000488	0.00176	CcSEcCtD
Phentolamine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000485	0.00175	CcSEcCtD
Phentolamine—Hypotension—Methylprednisolone—atopic dermatitis	0.000474	0.00171	CcSEcCtD
Phentolamine—Pain—Prednisolone—atopic dermatitis	0.000473	0.00171	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000466	0.00168	CcSEcCtD
Phentolamine—Pain—Hydrocortisone—atopic dermatitis	0.000462	0.00167	CcSEcCtD
Phentolamine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000456	0.00165	CcSEcCtD
Phentolamine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000455	0.00165	CcSEcCtD
Phentolamine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000452	0.00163	CcSEcCtD
Phentolamine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000452	0.00163	CcSEcCtD
Phentolamine—Tachycardia—Betamethasone—atopic dermatitis	0.00045	0.00163	CcSEcCtD
Phentolamine—Tachycardia—Dexamethasone—atopic dermatitis	0.00045	0.00163	CcSEcCtD
Phentolamine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000441	0.0016	CcSEcCtD
Phentolamine—Pain—Triamcinolone—atopic dermatitis	0.000435	0.00157	CcSEcCtD
Phentolamine—Hypotension—Betamethasone—atopic dermatitis	0.000431	0.00156	CcSEcCtD
Phentolamine—Hypotension—Dexamethasone—atopic dermatitis	0.000431	0.00156	CcSEcCtD
Phentolamine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000427	0.00154	CcSEcCtD
Phentolamine—Hypertension—Prednisone—atopic dermatitis	0.000425	0.00154	CcSEcCtD
Phentolamine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000415	0.0015	CcSEcCtD
Phentolamine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000414	0.0015	CcSEcCtD
Phentolamine—Paraesthesia—Betamethasone—atopic dermatitis	0.000414	0.0015	CcSEcCtD
Phentolamine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000401	0.00145	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000398	0.00144	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000398	0.00144	CcSEcCtD
Phentolamine—Pain—Dexamethasone—atopic dermatitis	0.000394	0.00143	CcSEcCtD
Phentolamine—Pain—Betamethasone—atopic dermatitis	0.000394	0.00143	CcSEcCtD
Phentolamine—Nervous system disorder—Prednisone—atopic dermatitis	0.000394	0.00142	CcSEcCtD
Phentolamine—Tachycardia—Prednisone—atopic dermatitis	0.000392	0.00142	CcSEcCtD
Phentolamine—Asthenia—Hydrocortisone—atopic dermatitis	0.000387	0.0014	CcSEcCtD
Phentolamine—Pruritus—Hydrocortisone—atopic dermatitis	0.000382	0.00138	CcSEcCtD
Phentolamine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000377	0.00136	CcSEcCtD
Phentolamine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000377	0.00136	CcSEcCtD
Phentolamine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000369	0.00133	CcSEcCtD
Phentolamine—Dizziness—Prednisolone—atopic dermatitis	0.000366	0.00132	CcSEcCtD
Phentolamine—Asthenia—Triamcinolone—atopic dermatitis	0.000365	0.00132	CcSEcCtD
Phentolamine—Abdominal pain—Betamethasone—atopic dermatitis	0.000365	0.00132	CcSEcCtD
Phentolamine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000365	0.00132	CcSEcCtD
Phentolamine—Asthenia—Methylprednisolone—atopic dermatitis	0.000364	0.00132	CcSEcCtD
Phentolamine—Paraesthesia—Prednisone—atopic dermatitis	0.000361	0.0013	CcSEcCtD
Phentolamine—Pruritus—Triamcinolone—atopic dermatitis	0.00036	0.0013	CcSEcCtD
Phentolamine—Pruritus—Methylprednisolone—atopic dermatitis	0.000359	0.0013	CcSEcCtD
Phentolamine—Dizziness—Hydrocortisone—atopic dermatitis	0.000357	0.00129	CcSEcCtD
Phentolamine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000347	0.00125	CcSEcCtD
Phentolamine—Headache—Prednisolone—atopic dermatitis	0.000346	0.00125	CcSEcCtD
Phentolamine—Vomiting—Hydrocortisone—atopic dermatitis	0.000343	0.00124	CcSEcCtD
Phentolamine—Headache—Hydrocortisone—atopic dermatitis	0.000338	0.00122	CcSEcCtD
Phentolamine—Dizziness—Triamcinolone—atopic dermatitis	0.000336	0.00121	CcSEcCtD
Phentolamine—Dizziness—Methylprednisolone—atopic dermatitis	0.000335	0.00121	CcSEcCtD
Phentolamine—Asthenia—Betamethasone—atopic dermatitis	0.000331	0.0012	CcSEcCtD
Phentolamine—Asthenia—Dexamethasone—atopic dermatitis	0.000331	0.0012	CcSEcCtD
Phentolamine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000328	0.00119	CcSEcCtD
Phentolamine—Nausea—Prednisolone—atopic dermatitis	0.000328	0.00119	CcSEcCtD
Phentolamine—Pruritus—Betamethasone—atopic dermatitis	0.000326	0.00118	CcSEcCtD
Phentolamine—Pruritus—Dexamethasone—atopic dermatitis	0.000326	0.00118	CcSEcCtD
Phentolamine—Vomiting—Triamcinolone—atopic dermatitis	0.000323	0.00117	CcSEcCtD
Phentolamine—Vomiting—Methylprednisolone—atopic dermatitis	0.000322	0.00117	CcSEcCtD
Phentolamine—Nausea—Hydrocortisone—atopic dermatitis	0.000321	0.00116	CcSEcCtD
Phentolamine—Headache—Triamcinolone—atopic dermatitis	0.000318	0.00115	CcSEcCtD
Phentolamine—Headache—Methylprednisolone—atopic dermatitis	0.000318	0.00115	CcSEcCtD
Phentolamine—Abdominal pain—Prednisone—atopic dermatitis	0.000318	0.00115	CcSEcCtD
Phentolamine—Diarrhoea—Betamethasone—atopic dermatitis	0.000316	0.00114	CcSEcCtD
Phentolamine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000316	0.00114	CcSEcCtD
Phentolamine—Dizziness—Dexamethasone—atopic dermatitis	0.000305	0.0011	CcSEcCtD
Phentolamine—Dizziness—Betamethasone—atopic dermatitis	0.000305	0.0011	CcSEcCtD
Phentolamine—Nausea—Triamcinolone—atopic dermatitis	0.000302	0.00109	CcSEcCtD
Phentolamine—Nausea—Methylprednisolone—atopic dermatitis	0.000301	0.00109	CcSEcCtD
Phentolamine—Vomiting—Betamethasone—atopic dermatitis	0.000293	0.00106	CcSEcCtD
Phentolamine—Vomiting—Dexamethasone—atopic dermatitis	0.000293	0.00106	CcSEcCtD
Phentolamine—Headache—Dexamethasone—atopic dermatitis	0.000289	0.00104	CcSEcCtD
Phentolamine—Headache—Betamethasone—atopic dermatitis	0.000289	0.00104	CcSEcCtD
Phentolamine—Asthenia—Prednisone—atopic dermatitis	0.000288	0.00104	CcSEcCtD
Phentolamine—Pruritus—Prednisone—atopic dermatitis	0.000284	0.00103	CcSEcCtD
Phentolamine—Diarrhoea—Prednisone—atopic dermatitis	0.000275	0.000993	CcSEcCtD
Phentolamine—Nausea—Betamethasone—atopic dermatitis	0.000274	0.00099	CcSEcCtD
Phentolamine—Nausea—Dexamethasone—atopic dermatitis	0.000274	0.00099	CcSEcCtD
Phentolamine—Dizziness—Prednisone—atopic dermatitis	0.000266	0.00096	CcSEcCtD
Phentolamine—Vomiting—Prednisone—atopic dermatitis	0.000255	0.000923	CcSEcCtD
Phentolamine—Headache—Prednisone—atopic dermatitis	0.000252	0.000909	CcSEcCtD
Phentolamine—Nausea—Prednisone—atopic dermatitis	0.000239	0.000862	CcSEcCtD
Phentolamine—ADRA2A—Signaling Pathways—FCER2—atopic dermatitis	3.96e-05	0.00135	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—TAC1—atopic dermatitis	3.96e-05	0.00135	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—NPS—atopic dermatitis	3.96e-05	0.00135	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—IL5—atopic dermatitis	3.94e-05	0.00135	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—NPS—atopic dermatitis	3.9e-05	0.00133	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—TAC1—atopic dermatitis	3.9e-05	0.00133	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CCR3—atopic dermatitis	3.88e-05	0.00133	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—CCL5—atopic dermatitis	3.88e-05	0.00133	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CXCR3—atopic dermatitis	3.88e-05	0.00133	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL17—atopic dermatitis	3.88e-05	0.00133	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—TAC1—atopic dermatitis	3.85e-05	0.00131	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—NPS—atopic dermatitis	3.85e-05	0.00131	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—KIF3A—atopic dermatitis	3.83e-05	0.00131	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CXCR3—atopic dermatitis	3.82e-05	0.00131	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CXCR3—atopic dermatitis	3.77e-05	0.00129	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—CCR5—atopic dermatitis	3.76e-05	0.00129	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GLB1—atopic dermatitis	3.75e-05	0.00128	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CXCL10—atopic dermatitis	3.72e-05	0.00127	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL22—atopic dermatitis	3.68e-05	0.00126	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—IL5—atopic dermatitis	3.68e-05	0.00126	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.66e-05	0.00125	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL17—atopic dermatitis	3.63e-05	0.00124	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—IL5—atopic dermatitis	3.62e-05	0.00124	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CCR3—atopic dermatitis	3.61e-05	0.00123	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—TAC1—atopic dermatitis	3.59e-05	0.00123	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—NPS—atopic dermatitis	3.59e-05	0.00123	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ADSL—atopic dermatitis	3.59e-05	0.00123	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL5—atopic dermatitis	3.58e-05	0.00122	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL17—atopic dermatitis	3.57e-05	0.00122	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—TAC1—atopic dermatitis	3.54e-05	0.00121	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—NPS—atopic dermatitis	3.54e-05	0.00121	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL27—atopic dermatitis	3.53e-05	0.00121	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CCR3—atopic dermatitis	3.53e-05	0.0012	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CXCR3—atopic dermatitis	3.53e-05	0.0012	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	3.51e-05	0.0012	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—CCR5—atopic dermatitis	3.5e-05	0.0012	CbGpPWpGaD
Phentolamine—ADRA2A—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.49e-05	0.00119	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CXCR3—atopic dermatitis	3.47e-05	0.00119	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CMA1—atopic dermatitis	3.47e-05	0.00118	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCL11—atopic dermatitis	3.47e-05	0.00118	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—NPS—atopic dermatitis	3.46e-05	0.00118	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—TAC1—atopic dermatitis	3.46e-05	0.00118	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—KIF3A—atopic dermatitis	3.46e-05	0.00118	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.42e-05	0.00117	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.39e-05	0.00116	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CXCL10—atopic dermatitis	3.38e-05	0.00115	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.36e-05	0.00115	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.36e-05	0.00115	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL5—atopic dermatitis	3.34e-05	0.00114	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL5—atopic dermatitis	3.29e-05	0.00112	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL27—atopic dermatitis	3.28e-05	0.00112	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CCR3—atopic dermatitis	3.28e-05	0.00112	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—STAT6—atopic dermatitis	3.26e-05	0.00111	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—KIF3A—atopic dermatitis	3.23e-05	0.0011	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—IL5—atopic dermatitis	3.22e-05	0.0011	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—TAC1—atopic dermatitis	3.22e-05	0.0011	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—NPS—atopic dermatitis	3.22e-05	0.0011	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CCL5—atopic dermatitis	3.2e-05	0.00109	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—KIF3A—atopic dermatitis	3.18e-05	0.00109	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL17—atopic dermatitis	3.17e-05	0.00108	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.15e-05	0.00108	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—NPS—atopic dermatitis	3.14e-05	0.00107	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—TAC1—atopic dermatitis	3.14e-05	0.00107	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CXCL10—atopic dermatitis	3.14e-05	0.00107	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CMA1—atopic dermatitis	3.13e-05	0.00107	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL11—atopic dermatitis	3.13e-05	0.00107	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.09e-05	0.00106	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—CXCL8—atopic dermatitis	3.09e-05	0.00105	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCR3—atopic dermatitis	3.08e-05	0.00105	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.08e-05	0.00105	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CXCL10—atopic dermatitis	3.05e-05	0.00104	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	2.99e-05	0.00102	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.99e-05	0.00102	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	2.95e-05	0.00101	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—STAT6—atopic dermatitis	2.94e-05	0.00101	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CMA1—atopic dermatitis	2.92e-05	0.000999	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL11—atopic dermatitis	2.92e-05	0.000999	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL5—atopic dermatitis	2.92e-05	0.000998	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	2.92e-05	0.000998	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	2.92e-05	0.000998	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CCL5—atopic dermatitis	2.91e-05	0.000994	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CCL5—atopic dermatitis	2.89e-05	0.000988	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CCR5—atopic dermatitis	2.89e-05	0.000986	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CMA1—atopic dermatitis	2.88e-05	0.000983	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL11—atopic dermatitis	2.88e-05	0.000983	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	2.86e-05	0.000978	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CXCL10—atopic dermatitis	2.85e-05	0.000974	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCR3—atopic dermatitis	2.83e-05	0.000965	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KIF3A—atopic dermatitis	2.83e-05	0.000965	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CXCL10—atopic dermatitis	2.8e-05	0.000958	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—CXCL8—atopic dermatitis	2.79e-05	0.000952	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.78e-05	0.000949	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—STAT6—atopic dermatitis	2.75e-05	0.000939	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.74e-05	0.000937	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	2.71e-05	0.000927	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—STAT6—atopic dermatitis	2.7e-05	0.000924	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CCL5—atopic dermatitis	2.7e-05	0.000923	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CCL5—atopic dermatitis	2.66e-05	0.000908	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CCL5—atopic dermatitis	2.63e-05	0.000897	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	2.63e-05	0.000897	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CCR5—atopic dermatitis	2.62e-05	0.000895	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CCR5—atopic dermatitis	2.61e-05	0.00089	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—CXCL8—atopic dermatitis	2.6e-05	0.000889	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—CXCL8—atopic dermatitis	2.56e-05	0.000875	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CMA1—atopic dermatitis	2.56e-05	0.000873	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL11—atopic dermatitis	2.56e-05	0.000873	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.55e-05	0.000872	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCR3—atopic dermatitis	2.55e-05	0.000871	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.55e-05	0.000871	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NPS—atopic dermatitis	2.52e-05	0.00086	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TAC1—atopic dermatitis	2.52e-05	0.00086	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCL10—atopic dermatitis	2.49e-05	0.000851	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCR3—atopic dermatitis	2.47e-05	0.000844	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CCL5—atopic dermatitis	2.45e-05	0.000838	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CCR5—atopic dermatitis	2.43e-05	0.000831	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CCL5—atopic dermatitis	2.41e-05	0.000825	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—STAT6—atopic dermatitis	2.4e-05	0.000821	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CCR5—atopic dermatitis	2.4e-05	0.000818	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCR3—atopic dermatitis	2.38e-05	0.000814	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—IL2—atopic dermatitis	2.38e-05	0.000814	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	2.37e-05	0.000811	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	2.37e-05	0.000811	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CCR5—atopic dermatitis	2.37e-05	0.000808	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CCL5—atopic dermatitis	2.36e-05	0.000807	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCR3—atopic dermatitis	2.34e-05	0.000801	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL5—atopic dermatitis	2.34e-05	0.0008	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	2.31e-05	0.000791	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	2.28e-05	0.000778	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TAC1—atopic dermatitis	2.27e-05	0.000777	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NPS—atopic dermatitis	2.27e-05	0.000777	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.27e-05	0.000775	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	2.23e-05	0.000763	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCR3—atopic dermatitis	2.23e-05	0.000762	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—IL2—atopic dermatitis	2.22e-05	0.00076	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CCR5—atopic dermatitis	2.21e-05	0.000755	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	2.19e-05	0.00075	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CCR5—atopic dermatitis	2.17e-05	0.000743	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	2.14e-05	0.000733	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	2.13e-05	0.000727	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TAC1—atopic dermatitis	2.12e-05	0.000726	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NPS—atopic dermatitis	2.12e-05	0.000726	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	2.11e-05	0.000722	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL5—atopic dermatitis	2.11e-05	0.000722	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TAC1—atopic dermatitis	2.09e-05	0.000714	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NPS—atopic dermatitis	2.09e-05	0.000714	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	2.08e-05	0.000712	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCR3—atopic dermatitis	2.08e-05	0.000712	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCR3—atopic dermatitis	2.05e-05	0.0007	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL10—atopic dermatitis	2e-05	0.000682	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.99e-05	0.000681	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.98e-05	0.000675	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	1.97e-05	0.000675	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	1.94e-05	0.000664	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.94e-05	0.000661	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	1.93e-05	0.00066	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	1.86e-05	0.000634	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	1.86e-05	0.000634	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	1.82e-05	0.000622	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—IL2—atopic dermatitis	1.81e-05	0.000617	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	1.8e-05	0.000616	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	1.79e-05	0.000613	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.74e-05	0.000596	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	1.73e-05	0.00059	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	1.72e-05	0.000589	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	1.72e-05	0.000589	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	1.72e-05	0.000587	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	1.69e-05	0.000578	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	1.68e-05	0.000575	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	1.67e-05	0.00057	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	1.66e-05	0.000566	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	1.6e-05	0.000548	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	1.59e-05	0.000544	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.58e-05	0.000541	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.58e-05	0.000538	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	1.55e-05	0.00053	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	1.55e-05	0.000529	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	1.51e-05	0.000517	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	1.51e-05	0.000514	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PPARA—atopic dermatitis	1.5e-05	0.000511	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	1.47e-05	0.000503	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.47e-05	0.000503	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	1.45e-05	0.000495	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.45e-05	0.000495	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	1.44e-05	0.000491	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.43e-05	0.000489	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	1.43e-05	0.000487	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	1.41e-05	0.00048	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	1.4e-05	0.000477	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	1.38e-05	0.000473	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	1.37e-05	0.000467	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	1.37e-05	0.000467	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	1.34e-05	0.000458	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	1.34e-05	0.000456	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	1.32e-05	0.000451	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.31e-05	0.000449	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.31e-05	0.000448	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	1.31e-05	0.000446	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.29e-05	0.000439	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	1.28e-05	0.000439	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	1.28e-05	0.000436	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	1.27e-05	0.000433	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	1.26e-05	0.000429	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	1.23e-05	0.00042	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PPARA—atopic dermatitis	1.22e-05	0.000415	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.2e-05	0.000408	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	1.18e-05	0.000405	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	1.18e-05	0.000402	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	1.17e-05	0.000401	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.17e-05	0.000399	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	1.14e-05	0.00039	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	1.14e-05	0.00039	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	1.12e-05	0.000381	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	1.11e-05	0.000378	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	1.09e-05	0.000372	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	1.09e-05	0.000372	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	1.09e-05	0.000371	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	1.06e-05	0.000362	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	1.04e-05	0.000354	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	9.68e-06	0.000331	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	9.36e-06	0.00032	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	8.99e-06	0.000307	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	8.94e-06	0.000306	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	8.9e-06	0.000304	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	8.45e-06	0.000289	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	8.23e-06	0.000281	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	8.07e-06	0.000276	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	8.03e-06	0.000275	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	7.89e-06	0.00027	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	7.77e-06	0.000265	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	7.54e-06	0.000258	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	7.51e-06	0.000256	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	7.43e-06	0.000254	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	7.42e-06	0.000254	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	7.39e-06	0.000252	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	6.94e-06	0.000237	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	6.9e-06	0.000236	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	6.83e-06	0.000233	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	6.59e-06	0.000225	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	6.56e-06	0.000224	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	6.41e-06	0.000219	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	6.13e-06	0.000209	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	6.1e-06	0.000208	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	6.07e-06	0.000207	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	5.64e-06	0.000193	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	5.26e-06	0.00018	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	4.75e-06	0.000162	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	4.43e-06	0.000151	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	4.36e-06	0.000149	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	3.88e-06	0.000132	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	3.6e-06	0.000123	CbGpPWpGaD
